Successful Heart Transplantation After Desensitization in a Patient With Extremely High Panel-Reactive Antibody Levels and Pretransplant Donor-Specific Antibody: A Case Report.
Transplant Proc
; 50(10): 4067-4070, 2018 Dec.
Article
em En
| MEDLINE
| ID: mdl-30577317
Elevated panel-reactive antibody (PRA) levels serve as a significant risk factor for allograft survival and episodes of rejection after heart transplantation (HTX). Patients with high PRA levels tend to show expressions of donor-specific human leukocyte antigen antibodies (DSA), which can cause catastrophic hyperacute rejection after HTX. Therefore, such highly sensitized patients are required to undergo strategic perioperative desensitization therapy. We describe a successful HTX after desensitization in a patient with extremely high PRA levels and pretransplant DSA positivity.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dessensibilização Imunológica
/
Transplante de Coração
/
Antígenos HLA
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article